Dr. Lisa A Kuhar, MD, MPH Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 149 Hart St, Suite 3, Sheppard Afb, TX 76311 Phone: 940-676-6509 Fax: 940-676-7626 |
Dr. Blaine Smith Purcell, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 149 Hart St, Sheppard Afb, TX 76311 Phone: 940-676-7048 Fax: 940-676-3730 |
Dr. Carmella Louise D'addezio, D.O. Internal Medicine - Nephrology Medicare: Not Enrolled in Medicare Practice Location: 149 Hart St, 82 Mdg/sgop, Sheppard Afb, TX 76311 Phone: 940-676-4472 Fax: 950-676-8005 |
News Archive
Starting in February 2011, Springer will publish a new international, peer-reviewed journal Drug Delivery and Translational Research. Focusing exclusively on translational aspects of drug delivery, the bi-monthly journal will provide a unique forum for publication of high-quality research. It is an official journal of the Controlled Release Society (CRS).
BioMimetic Therapeutics, Inc. today announced that it has received orphan drug designation from the Food and Drug Administration for its protein therapeutic, recombinant human platelet derived growth factor, to be used in conjunction with autograft and/or commercially available osteochondral allograft for the treatment of osteochondritis dissecans of the knee, elbow or ankle.
Wisdom has gained increasing interest among researchers over the last few decades as a biologically based personality trait relevant to physical well-being and mental health.
Imagine being able to tone down appetite and promote weight loss, while improving the body's ability to handle blood sugar levels.
GlaxoSmithKline and XenoPort, Inc. announced today that the U.S. Food and Drug Administration (FDA) has accepted for review GSK's response to FDA's Complete Response letter for Horizant (gabapentin enacarbil) Extended-Release Tablets. Horizant is under review for the treatment of moderate-to-severe primary Restless Legs Syndrome (RLS).
› Verified 1 days ago